Literature DB >> 25284106

Neuro-ophthalmic presentations and treatment of Cryptococcal meningitis-related increased intracranial pressure.

Angelina Espino Barros Palau1, Michael L Morgan1, Rod Foroozan2, Andrew G Lee3.   

Abstract

OBJECTIVE: To illustrate three different ophthalmic presentations of cryptococcal meningitis (CM).
INTRODUCTION: CM is the most common manifestation of extra-pulmonary cryptococcosis. Intracranial hypertension occurs in up to 75% of patients with CM and is associated with increased mortality. CM can present to the ophthalmologist as vision loss, papilledema, abducens palsy, and/or other cranial neuropathies. PARTICIPANTS AND METHODS: We report three cases, two C. neoformans and one C. gattii, highlighting the various CM presentations. The first was a woman immunosuppressed following kidney transplantation in whom idiopathic intracranial hypertension (IIH) was initially suspected. The second was a man immunocompromised by previously undiagnosed HIV/AIDS who presented with signs and symptoms of increased intracranial pressure. The third case is an immunocompetent man with bilateral disc edema and an incomplete macular star diagnosed with presumed neuroretinitis. Further evaluation revealed positive CSF cryptococcal antigen with culture positive for C. gattii.
CONCLUSIONS: Ophthalmologists should be aware that cryptococcosis can mimic more benign etiologies including IIH and neuroretinitis. Additionally, C. gattii, an emerging organism, can infect immunocompetent patients. In contrast to the typical treatment of increased ICP, serial lumbar punctures are recommended while acetazolamide and surgical CSF shunting may be harmful.
Copyright © 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25284106     DOI: 10.1016/j.jcjo.2014.06.012

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  7 in total

Review 1.  Should Lumbar Puncture Be Required to Diagnose Every Patient With Idiopathic Intracranial Hypertension?

Authors:  Heather E Moss; Edward A Margolin; Andrew G Lee; Gregory P Van Stavern
Journal:  J Neuroophthalmol       Date:  2021-09-01       Impact factor: 4.415

2.  Cryptococcal meningitis initially presenting with eye symptoms in an immunocompetent patient: A case report.

Authors:  Jun Li; Peipei Wang; Ling Ye; Yanfang Wang; Xiuzhen Zhang; Songping Yu
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

Review 3.  Cryptococcal meningitis: a review for emergency clinicians.

Authors:  Kathryn Marie Fisher; Tim Montrief; Mark Ramzy; Alex Koyfman; Brit Long
Journal:  Intern Emerg Med       Date:  2021-01-09       Impact factor: 3.397

4.  Ophthalmic manifestations of Cryptococcus gattii species complex: a case series and review of the literature.

Authors:  Grace A McCabe; Jack W McHugh; Todd Goodwin; Douglas F Johnson; Anthony Fok; Thomas G Campbell
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

5.  MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil.

Authors:  Diego Fernando Silva Rocha; Katia Santana Cruz; Carla Silvana da Silva Santos; Lizandra Stephanny Fernandes Menescal; João Ricardo da Silva Neto; Silviane Bezerra Pinheiro; Lucyane Mendes Silva; Luciana Trilles; João Vicente Braga de Souza
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

6.  Acute vision loss in post-partum period as presenting symptom of HIV-associated cryptococcal meningitis-an unusual case report.

Authors:  Aniruddha More; Ravindra Kumar Garg; Hardeep Singh Malhotra; Neeraj Kumar; Ravi Uniyal
Journal:  BMC Infect Dis       Date:  2016-10-19       Impact factor: 3.090

7.  Ophthalmic signs in Ugandan adults with HIV-associated cryptococcal meningitis: A nested analysis of the ASTRO-CM cohort.

Authors:  Rachel R Atherton; Jayne Ellis; Fiona V Cresswell; Joshua Rhein; David R Boulware
Journal:  Wellcome Open Res       Date:  2018-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.